I’m not naming a Best Biopharma CEO this year.
I tried — doing so, after all, is an annual exercise — but in a year in which biotech and pharma mostly went sideways, none of the executives I considered stood out enough individually to win over the others.
On a more encouraging note, I managed to compile an impressively deep list of biopharma CEOs whose accomplishments this year deserve recognition. Let’s have a look.